269 related articles for article (PubMed ID: 33431814)
1. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
[TBL] [Abstract][Full Text] [Related]
2. Genetic and non-genetic clonal diversity in cancer evolution.
Black JRM; McGranahan N
Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2020 Jul; 26(26):3720-3736. PubMed ID: 32774053
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer.
Shetty S; Lujambio A; Tacke F
Front Immunol; 2021; 12():707329. PubMed ID: 34149741
[No Abstract] [Full Text] [Related]
5. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
6. Genomic-transcriptomic evolution in lung cancer and metastasis.
Martínez-Ruiz C; Black JRM; Puttick C; Hill MS; Demeulemeester J; Larose Cadieux E; Thol K; Jones TP; Veeriah S; Naceur-Lombardelli C; Toncheva A; Prymas P; Rowan A; Ward S; Cubitt L; Athanasopoulou F; Pich O; Karasaki T; Moore DA; Salgado R; Colliver E; Castignani C; Dietzen M; Huebner A; Al Bakir M; Tanić M; Watkins TBK; Lim EL; Al-Rashed AM; Lang D; Clements J; Cook DE; Rosenthal R; Wilson GA; Frankell AM; de Carné Trécesson S; East P; Kanu N; Litchfield K; Birkbak NJ; Hackshaw A; Beck S; Van Loo P; Jamal-Hanjani M; ; Swanton C; McGranahan N
Nature; 2023 Apr; 616(7957):543-552. PubMed ID: 37046093
[TBL] [Abstract][Full Text] [Related]
7. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity.
Wang Y; Xu J; Lan T; Zhou C; Liu P
Cancer Med; 2023 Dec; 12(24):21651-21665. PubMed ID: 37965778
[TBL] [Abstract][Full Text] [Related]
8. Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.
López-Carrasco A; Berbegall AP; Martín-Vañó S; Blanquer-Maceiras M; Castel V; Navarro S; Noguera R
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680323
[TBL] [Abstract][Full Text] [Related]
9. Decoding Cancer Evolution: Integrating Genetic and Non-Genetic Insights.
Ashouri A; Zhang C; Gaiti F
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895205
[TBL] [Abstract][Full Text] [Related]
10. Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities.
Kalasekar SM; VanSant-Webb CH; Evason KJ
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771685
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.
Gavish A; Tyler M; Greenwald AC; Hoefflin R; Simkin D; Tschernichovsky R; Galili Darnell N; Somech E; Barbolin C; Antman T; Kovarsky D; Barrett T; Gonzalez Castro LN; Halder D; Chanoch-Myers R; Laffy J; Mints M; Wider A; Tal R; Spitzer A; Hara T; Raitses-Gurevich M; Stossel C; Golan T; Tirosh A; Suvà ML; Puram SV; Tirosh I
Nature; 2023 Jun; 618(7965):598-606. PubMed ID: 37258682
[TBL] [Abstract][Full Text] [Related]
12. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications.
Gerlinger M; Catto JW; Orntoft TF; Real FX; Zwarthoff EC; Swanton C
Eur Urol; 2015 Apr; 67(4):729-37. PubMed ID: 24836153
[TBL] [Abstract][Full Text] [Related]
13. Lineage and ecology define liver tumor evolution in response to treatment.
Revsine M; Wang L; Forgues M; Behrens S; Craig AJ; Liu M; Tran B; Kelly M; Budhu A; Monge C; Xie C; Hernandez JM; Greten TF; Wang XW; Ma L
Cell Rep Med; 2024 Feb; 5(2):101394. PubMed ID: 38280378
[TBL] [Abstract][Full Text] [Related]
14. Impact of cancer evolution on immune surveillance and checkpoint inhibitor response.
Wu Y; Biswas D; Swanton C
Semin Cancer Biol; 2022 Sep; 84():89-102. PubMed ID: 33631295
[TBL] [Abstract][Full Text] [Related]
15. Tumor phylogeography reveals block-shaped spatial heterogeneity and the mode of evolution in Hepatocellular Carcinoma.
Liu X; Zhang K; Kaya NA; Jia Z; Wu D; Chen T; Liu Z; Zhu S; Hillmer AM; Wuestefeld T; Liu J; Chan YS; Hu Z; Ma L; Jiang L; Zhai W
Nat Commun; 2024 Apr; 15(1):3169. PubMed ID: 38609353
[TBL] [Abstract][Full Text] [Related]
16. Clinical and translational relevance of intratumor heterogeneity.
Goyette MA; Lipsyc-Sharf M; Polyak K
Trends Cancer; 2023 Sep; 9(9):726-737. PubMed ID: 37248149
[TBL] [Abstract][Full Text] [Related]
17. Quantification of within-sample genetic heterogeneity from SNP-array data.
Martinez P; Kimberley C; BirkBak NJ; Marquard A; Szallasi Z; Graham TA
Sci Rep; 2017 Jun; 7(1):3248. PubMed ID: 28607403
[TBL] [Abstract][Full Text] [Related]
18. Mutation divergence over space in tumour expansion.
Li H; Yang Z; Tu F; Deng L; Han Y; Fu X; Wang L; Gu D; Werner B; Huang W
J R Soc Interface; 2023 Nov; 20(208):20230542. PubMed ID: 37989227
[TBL] [Abstract][Full Text] [Related]
19. Tumour Cell Heterogeneity.
Gay L; Baker AM; Graham TA
F1000Res; 2016; 5():. PubMed ID: 26973786
[TBL] [Abstract][Full Text] [Related]
20. In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome.
Piñeiro-Yáñez E; Jiménez-Santos MJ; Gómez-López G; Al-Shahrour F
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
